Previous Page  25 / 30 Next Page
Information
Show Menu
Previous Page 25 / 30 Next Page
Page Background

allied

academies

Journal of Physical Therapy and Sports Medicine

Volume 1, Issue 1

Euro Physiotherapy 2017

Notes:

Page 54

December 07-08, 2017 Rome, Italy

4

th

Euro-Global Physiotherapy Congress 2017

Safety and efficacy of stem cell therapy in

ambulatory and non-ambulatory children

with duchene muscular dystrophy

Wael Abo El-Kheir

1

, Osama Ghannam

2

, Esey El-Fiki

3

and

Hala Gabr

4

1

Military Medical Academy, Egypt

2

Azhar University, Egypt

3

Alexandria University, Egypt

4

Cairo University, Egypt

D

uchenne muscular dystrophy (DMD) is the most

common muscular dystrophy of childhood. This

incurable disease is characterized by muscle wasting

and loss of walking ability leading to complete wheelchair

dependence by 13 years of age. Prolongation of walking

is one of the major aims of treatment. This study is to

investigate the effects of allogenic mesenchymal stem

cell therapy in ambulatory and children with Duchene

Muscular Dystrophy and determine its suitability as a form

of treatment. This study was conducted on 35 myopathic

children 12 ambulatory, 10 non-ambulatory and 13

control (seven ambulatory and six on-ambulatory) aged

from 4-14 years. The control groups taken the traditional

treatment (physiotherapy and medical treatment drugs)

and the studied groups taken the same treatment

with allogenic bone marrow mesenchymal stem cells

intramuscular and systemic IV. Assesment was done by

North Star ambulatory assessment CHAQ (Child Health

Assessment Questionnaire) MRI/MRS Muscle Strength

Assessment -Myogrip, Myopinch, and Moviplate, manual

muscle strength testing using Medical Research Council

strength scores, functional outcome measures before and

after every three months for two years long and adverse

effect and complications inspected. There were significant

differences in assessment scores and quality of life

questionnaire between studied groups vs. control group.

There was minimal adverse effect and complications.

Biography

Wael Abo El-Kheir is currently works as Professor of immunology &

Microbiology in military medical academy and he is the member of

the national committee for stem cells Egyptian ministry of health and also

honor as secretary of the Egyptian society of stem cells.

dr.wael2008@yahoo.com

Wael Abo El-kheir et al., J Phys Ther Sports Med 2017